Delivery Order SPE2DB20D2002-SPE2DB25FL50Q
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units) with a contract ceiling value of $1,206.33. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100 units, with a ceiling value of $4,545.64. This firm fixed price contract was awarded on September 18, 2025, with an ultimate completion date of September 19, 2025, and represents a non-competitive set-aside delivery order. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $6,951.06 delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100, with an ultimate completion date of May 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The product will be delivered to the company's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100 units, with a ceiling value of $2,021.12. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,584.77 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1 mg capsules (immediate-release formulation) in quantities of 100 units. The contract carries a firm fixed price structure with an ultimate completion date of June 2, 2025. This non-set-aside competitive award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100, with a contract ceiling value of $3,248.74. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The ultimate...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $3,512.26 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1mg in quantities of 100 units. The contract, awarded on August 7, 2025, with an ultimate completion date of September 4, 2025, utilizes firm fixed-price pricing under a non-set-aside competitive procurement. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tacrolimus 5 mg capsules (immediate-release). The contract is valued at $4,320.54 and has a period of performance through September 26, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and is used to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tacrolimus 1 mg capsules, an immunosuppressant medication, with a ceiling value of $8,462.05 and a period of performance through June 24, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $305 to Amerisourcebergen Drug Corporation for tacrolimus 1 mg capsules. As the prime contractor, Amerisourcebergen will deliver 100 capsules to a facility in Conshohocken, Pennsylvania, completing performance within a day of the order's placement in mid-August 2023. The order was placed under an existing DLA contract vehicle, though details were not provided. As a top provider of pharmaceuticals and medical...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL50QDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,009.52 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1 mg capsules (immediate release formulation) in quantities of 100 units. The award, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, carries a firm fixed price and represents a competitively awarded, non-set-aside contract. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a prime vendor for pharmaceutical and medical supply distribution, AmerisourceBergen leverages this comprehensive global contract vehicle to fulfill federal medical procurement requirements across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Tacrolimus supply supports military healthcare operations requiring immunosuppressive pharmaceutical products for transplant recipients and other clinical applications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 6/18/25 |